Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions

Qingqing Wu,1,2 Xiaodong Wang,3 Qian Chen,1,2 Yang Zou,1,2 Xiaoyan Xu,1,2 Tingting Li,1,2 Chen Yu,1,2 Fu Zhu,1,2 Kanyin E Zhang,4 Jingying Jia,1,2 Yanmei Liu1,2 1Center Laboratory, Shanghai Xuhui Central Hospital, Shanghai, People’s Republic of China; 2Shanghai Engineering Research Center...

Full description

Bibliographic Details
Main Authors: Wu Q, Wang X, Chen Q, Zou Y, Xu X, Li T, Yu C, Zhu F, Zhang KE, Jia J, Liu Y
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Drug Design, Development and Therapy
Subjects:
valsartan
bioequivalence
replicate
pharmacokinetics
safety
Online Access:https://www.dovepress.com/pharmacokinetics-and-bioequivalence-of-two-formulations-of-valsartan-8-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/pharmacokinetics-and-bioequivalence-of-two-formulations-of-valsartan-8-peer-reviewed-article-DDDT

Similar Items